Sinopharm-CICC logo

Sinopharm-CICC

Asia, Shanghai, China, Shanghai

Description

Sinopharm-CICC is a private equity fund focused on investments in the healthcare industry under CICC Capital.

Investor Profile

Sinopharm-CICC has made 2 investments, with 1 in the past 12 months and 50% as lead.

Stage Focus

  • Series C (50%)
  • Series B (50%)

Country Focus

  • China (100%)

Industry Focus

  • Health Care
  • Pharmaceutical
  • Medical
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sinopharm-CICC frequently co-invest with?

DNV capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Hongtai Capital Holdings
Asia, Beijing, China, Beijing
Co-Investments: 1
IG
Europe, England, United Kingdom, London
Co-Investments: 1
Huarong Rongde Asset Management
Asia, Beijing, China, Beijing
Co-Investments: 1
Sealand Securities
Asia, Guangdong, China, Nanning
Co-Investments: 1
Guangzhou Industrial Investment Group
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
CCB International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Shenzhen Investment Holdings
Asia, Guangdong, China, Futian
Co-Investments: 1
Founder H Fund
Asia, Beijing, China, Beijing
Co-Investments: 1
Tigermed
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1

What are some of recent deals done by Sinopharm-CICC?

Boyin Hearing

Minhang, Shanghai, China

Boyin Hearing offers a comprehensive selection of hearing treatments for persons suffering from hearing loss.

Health CareMedicalMedical Device
Series BJan 1, 2025
Amount Raised: $13,702,572
Hinova Pharma

Chengdu, Sichuan, China

Hinova Pharma is a pharmaceutical company.

Health CarePharmaceutical
Series COct 6, 2020
Amount Raised: $147,258,055